| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | 0 |
Sells | $5 | 2 | 100 |
| Brady Brian Michael | director | 0 | $0 | 1 | $2 | $-2 |
| Pankovcin Corinne | Chief M&A Officer | 0 | $0 | 1 | $3 | $-3 |
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Over the last 12 months, insiders at Aditxt, Inc. have bought $0 and sold $5 worth of Aditxt, Inc. stock.
On average, over the past 5 years, insiders at Aditxt, Inc. have bought $37,727 and sold $240,340 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 15,636 shares for transaction amount of $23,454 was made by HRT FINANCIAL LP (10 percent owner) on 2024‑10‑15.
| 2025-12-17 | Sale | Brady Brian Michael | director | 1 <0.0001% | $1.75 | $2 | -51.97% | |
| 2025-11-25 | Sale | Pankovcin Corinne | Chief M&A Officer | 1 <0.0001% | $3.20 | $3 | -64.74% | |
| 2024-10-16 | Sale | HRT FINANCIAL LP | 10 percent owner | 25,534 2.5257% | $1.17 | $29,875 | -99.17% | |
| 2024-10-15 | HRT FINANCIAL LP | 10 percent owner | 15,636 1.9829% | $1.50 | $23,454 | -99.16% | ||
| 2023-09-07 | Sale | BNP PARIBAS SECURITIES CORP | 20,800 12.7911% | $33.23 | $691,140 | -88.55% | ||
| 2022-07-19 | Albanna Amro A. | Chief Executive Officer | 1 – | $20,000.00 | $20,000 | -64.20% | ||
| 2021-06-01 | Shabahang Shahrokh | CHIEF INNOVATION OFFICER | 490 0.0034% | $2.93 | $1,436 | |||
| 2021-06-01 | Albanna Rowena | CHIEF OPERATING OFFICER | 3,400 0.0238% | $2.93 | $9,974 | |||
| 2021-06-01 | Albanna Amro A. | CHIEF EXECUTIVE OFFICER | 3,400 0.0238% | $2.93 | $9,974 | |||
| 2021-06-01 | Runge Jeffrey W. | director | 10,000 0.07% | $2.93 | $29,344 | |||
| 2021-05-27 | Shabahang Shahrokh | CHIEF INNOVATION OFFICER | 185 0.0013% | $2.70 | $500 | |||
| 2021-05-26 | Farley Thomas J | PRINCIPAL ACCOUNTING OFFICER | 2,500 0.0172% | $2.68 | $6,700 | |||
| 2021-05-25 | Shabahang Shahrokh | CHIEF INNOVATION OFFICER | 417 0.0026% | $2.39 | $998 | |||
| 2021-05-25 | Pankovcin Corinne | CHIEF FINANCIAL OFFICER | 4,220 0.0279% | $2.56 | $10,803 |
| Brady Brian Michael | director | 3 0.0139% | $1.82 | 0 | 1 | |
| Pankovcin Corinne | Chief M&A Officer | 0 0% | $0 | 1 | 1 | |
| Shabahang Shahrokh | CHIEF INNOVATION OFFICER | 1016098 4722.6871% | $616,263.44 | 3 | 0 | |
| Albanna Rowena | CHIEF OPERATING OFFICER | 751620 3493.4288% | $455,857.53 | 1 | 0 | |
| BNP PARIBAS SECURITIES CORP | 22342 103.8426% | $13,550.42 | 0 | 1 | ||
| Runge Jeffrey W. | director | 12500 58.0983% | $7,581.25 | 1 | 0 | |
| Farley Thomas J | PRINCIPAL ACCOUNTING OFFICER | 2500 11.6197% | $1,516.25 | 1 | 0 | |
| Albanna Amro A. | Chief Executive Officer | 1 0.0046% | $0.61 | 2 | 0 | |
| HRT FINANCIAL LP | 10 percent owner | 0 0% | $0 | 1 | 1 | <0.0001% |
$1,848,072 | 66 | -14.67% | $2.37M | |
$1,138,733 | 28 | -4.94% | $3.39M | |
$8,079,884 | 14 | -43.20% | $1.31M | |
$82,890 | 11 | -16.74% | $1.6M | |
$105,917 | 11 | -28.06% | $2.28M | |
$126,023 | 10 | -66.17% | $2.59M | |
$18,269 | 10 | -21.15% | $2.41M | |
$90,087 | 9 | 20.06% | $2.17M | |
$7,268,979 | 7 | -48.44% | $2.59M | |
$245,000 | 7 | -62.00% | $3.12M | |
$70,828 | 6 | -57.96% | $1.54M | |
$553,551 | 4 | -74.30% | $477,533.00 | |
$149,778 | 4 | -45.16% | $3.17M | |
$726,438 | 4 | -72.85% | $1.03M | |
$1,049,630 | 1 | -74.91% | $858,762.00 | |
$9,963 | 1 | -14.25% | $2.4M | |
$19,863 | 1 | 144.27% | $1.14M | |
$37,000 | 1 | 79.42% | $2.62M | |
Aditxt, Inc. (ADTX) | $23,454 | 1 | -99.16% | $13,049.00 |
| Increased Positions | 11 | +110% | 41,931 | +11,487.95% |
| Decreased Positions | 5 | -50% | 184 | -50.41% |
| New Positions | 9 | New | 41,306 | New |
| Sold Out Positions | 4 | Sold Out | 144 | Sold Out |
| Total Postitions | 16 | +60% | 42,112 | +11,437.53% |